TY - JOUR
T1 - From Idealist to Realist-Designing and Implementing Shared Decision-Making Interventions in the Choice of Antipsychotic Prescription in People Living with Psychosis (SHAPE): A Realist Review: Part 1 - Implementing Shared Decision-Making: Policy, Governance and System Factors
AU - Fitzgerald, Ita
AU - Sahm, Laura J.
AU - Maidment, Ian
AU - Wallace, Emma
AU - Zisman-Ilani, Yaara
AU - Hojlund, Mikkel
AU - O'Dwyer, Sarah
AU - Dhubhlaing, Ciara Ni
AU - Crowley, Erin K.
AU - Howe, Jo
N1 - Copyright © The Author(s) 2025. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
PY - 2025/7
Y1 - 2025/7
N2 - Background: Shared decision-making (SDM) implementation remains limited in psychosis management, particularly within antipsychotic prescribing. When and why prescribers engage in SDM within these contexts is largely unknown. Part 1 of this two-part realist review aimed to understand the impact of structural and contextual factors on prescriber engagement in SDM within antipsychotic prescribing.Study design: CINAHL Plus, Cochrane Library, Embase, PsycINFO, PubMed, Scopus, Sociological Abstracts, Web of Science and Google Scholar were searched for evidence to develop realist programme theories outliningthe relationship between macro-level contexts and their impact on prescriber behaviours.Study results: From 106 included documents, five programme theories explaining relationships between (i) leadership and governance, (ii) workforce development and (iii) service delivery contexts and their impact on reducing prescriber engagement with behaviours required of SDM application were developed. No facilitative macro-level contexts were identified. Key mechanisms reducing prescriber engagement in desired behaviours include fear of individual blame for adverse outcomes and exposure to liability, pressure from serviceenvironments to prioritise decreasing risk of harm, devaluing of experiential knowledge and beliefs that SDM conflicts with duties of beneficence and non-maleficence.Conclusion: Even empirically efficacious interventions will be difficult to implement at scale within real-world settings due to misalignment with complex cultural, legal and professional realities prominent therein. Mechanisms responsible for reducing prescriber engagement in SDM should be the target of structural interventions necessary to support contextual integration into psychosis management. Part 2 outlines features of service delivery contexts, workforce development and technology that can increase prescriber engagement in SDM.
AB - Background: Shared decision-making (SDM) implementation remains limited in psychosis management, particularly within antipsychotic prescribing. When and why prescribers engage in SDM within these contexts is largely unknown. Part 1 of this two-part realist review aimed to understand the impact of structural and contextual factors on prescriber engagement in SDM within antipsychotic prescribing.Study design: CINAHL Plus, Cochrane Library, Embase, PsycINFO, PubMed, Scopus, Sociological Abstracts, Web of Science and Google Scholar were searched for evidence to develop realist programme theories outliningthe relationship between macro-level contexts and their impact on prescriber behaviours.Study results: From 106 included documents, five programme theories explaining relationships between (i) leadership and governance, (ii) workforce development and (iii) service delivery contexts and their impact on reducing prescriber engagement with behaviours required of SDM application were developed. No facilitative macro-level contexts were identified. Key mechanisms reducing prescriber engagement in desired behaviours include fear of individual blame for adverse outcomes and exposure to liability, pressure from serviceenvironments to prioritise decreasing risk of harm, devaluing of experiential knowledge and beliefs that SDM conflicts with duties of beneficence and non-maleficence.Conclusion: Even empirically efficacious interventions will be difficult to implement at scale within real-world settings due to misalignment with complex cultural, legal and professional realities prominent therein. Mechanisms responsible for reducing prescriber engagement in SDM should be the target of structural interventions necessary to support contextual integration into psychosis management. Part 2 outlines features of service delivery contexts, workforce development and technology that can increase prescriber engagement in SDM.
KW - Antipsychotic Agents/therapeutic use
KW - Decision Making, Shared
KW - Humans
KW - Psychotic Disorders/drug therapy
UR - https://academic.oup.com/schizophreniabulletin/advance-article/doi/10.1093/schbul/sbaf058/8139757
UR - http://www.scopus.com/inward/record.url?scp=105010885067&partnerID=8YFLogxK
U2 - 10.1093/schbul/sbaf058
DO - 10.1093/schbul/sbaf058
M3 - Review article
C2 - 40396340
SN - 0586-7614
VL - 51
SP - 916
EP - 932
JO - Schizophrenia Bulletin
JF - Schizophrenia Bulletin
IS - 4
M1 - sbaf058
ER -